Cited by 188Blood Pressure and Hypertension StudiesRenal and Vascular PathologiesCardiovascular Health and Disease Prevention

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Open access
Barbato, Emanuele, Azizi, Michel, Schmieder, Roland E, Lauder, Lucas, Böhm, Michael, Brouwers, Sofie, Bruno, Rosa Maria, Dudek, Dariusz +13 more·2023·European Heart Journal

Abstract

Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several high-quality studies, including randomised, sham-controlled trials on catheter-based renal denervation (RDN) were published, confirming both the blood pressure (BP)-lowering efficacy and safety of radiofrequency and ultrasound RDN in a broad range of patients with hypertension, including resistant hypertension. A clinical consensus document by the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on RDN in the management of hypertension was considered necessary to inform clinical practice. This expert group proposes that RDN is an adjunct treatment option in uncontrolled resistant hypertension, confirmed by ambulatory BP measurements, despite best efforts at lifestyle and pharmacological interventions. RDN may also be used in patients who are unable to tolerate antihypertensive medications in the long term. A shared decision-making process is a key feature and preferably includes a patient who is well informed on the benefits and limitations of the procedure. The decision-making process should take (i) the patient’s global cardiovascular (CV) risk and/or (ii) the presence of hypertension-mediated organ damage or CV complications into account. Multidisciplinary hypertension teams involving hypertension experts and interventionalists evaluate the indication and facilitate the RDN procedure. Interventionalists require expertise in renal interventions and specific training in RDN procedures. Centres performing these procedures require the skills and resources to deal with potential complications. Future research is needed to address open questions and investigate the impact of BP-lowering with RDN on clinical outcomes and potential clinical indications beyond hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehad054

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 2023, clinical adoption of renal denervation was recommended by guidelines from the International Society of Hypertension and the European Renal Association, and from the European Society of Cardiology Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions.

    “clinical adoption of RDN was recommended in 2023 guidelines from the International Society of Hypertension and the European Renal Association15, and from the European Society of Cardiology Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions16,17”

    From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [16]

    The Introduction (p. 2) identifies this 2023 paper as a clinical consensus document of the ESC Council on Hypertension and EAPCI, and Centre selection (p. 9) recommends teams to evaluate indications for and perform renal denervation. Calling it a guideline recommending general clinical adoption overstates the source: it gives conditional consensus statements about patient selection and centre requirements. The International Society of Hypertension and European Renal Association portion is attached to a different citation and is not assessed here. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [42]42. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 ; 76:2982-3021.
  2. [45]45. Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014; 384 :591-8.
  3. [49]49. Burnier M, Egan BM. Adherence in Hypertension. Circ Res . 2019; 124 :1124-40.
  4. [67]67. Finkelstein DM, Schoenfeld DA. Combining mortality and longitudinal measures in clin­ ical trials. Stat Med . 1999; 18 :1341-54.

Cited by

Sorted by citations

Authors
Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., Lüscher, T. F., Parati, G., Pathak, A., Ribichini, F. L., Schlaich, M. P., Sharp, A. S. P., Sudano, I., Volpe, M., Tsioufis, C., Wijns, W., & Mahfoud, F.
Affiliations
  • Sapienza University of Rome (IT)
  • Inserm (FR)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Universitätsklinikum des Saarlandes (DE)
  • Vrije Universiteit Brussel (BE)
  • Paris Centre de Recherche Cardiovasculaire, INSERM, Université Paris Cité , Paris ,
  • Jagiellonian University (PL)
  • Danderyds sjukhus (SE)
  • Piedmont Atlanta Hospital (US)
  • King's College London (GB)
  • IRCCS Istituto Auxologico Italiano (IT)
  • Princess Grace Hospital Centre (MC)
  • University of Verona (IT)
  • The University of Western Australia (AU)
  • University Hospital of Wales (GB)
  • University Hospital Zurich (CH)
  • Azienda Ospedaliera Sant'Andrea (IT)
  • National and Kapodistrian University of Athens (GR)
  • Ollscoil na Gaillimhe – University of Galway (IE)
Corresponding author
Mahfoud, Felix
Venue
European Heart Journal
Published
2023-02-15
Volume
44
Issue
15
Pages
1313-1330
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4320855364
Cited by
188
References
97
Citations by year
2026: 39 · 2025: 52 · 2024: 62 · 2023: 35
FWCI
36.95
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
renal denervation, resistant hypertension, hypertension, radiofrequency ablation, ultrasound ablation, blood pressure reduction, shared decision-making, cardiovascular risk, hypertension-mediated organ damage, procedural complications
MeSH terms
Adult, Antihypertensive Agents, Blood Pressure, Denervation, Humans, Hypertension, Kidney, Renal Artery, Sympathectomy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review